BLOOD TRANSFUSION SAFETY: PROGRESS REPORT 142 nd Session of the Executive Committee 23-29 June 2008, Washington DC Pan American Health Organization 142.

Slides:



Advertisements
Similar presentations
Contribution of the Americas to the WCDR Inter American Committee for Natural Disaster Reduction OAS, PAHO/WHO, IDB, IICA, …
Advertisements

Progress Through Partnerships. Who we are  Founded in 1964 as the people-to-people component of the Alliance for Progress  Partners of the Americas.
FDA Workshop “Data and Data Needs to Advance Risk Assessment for Emerging Infectious Diseases for Blood and Blood Products” November 29, 2011, Gaithersburg.
U.S. Food and Drug Administration Notice: Archived Document. The content in this document is provided on the FDA’s website for reference purposes only.
Carla Peterson, President Elect ADRP International Blood Safety Forum, March 20, 2015 A Global Network Dedicated to SHARING Information to Improve the.
Public Workshop: Quarantine Release Errors in Blood Establishments September 13, 2011 QREs Past, Present and Future Sheryl A. Kochman Deputy Director Division.
HIV/AIDS AMONG LATINOS IN NEW JERSEY presented by: Gloria M. Rodriguez, DSW Assistant Commissioner Division of AIDS Prevention and Control presented at.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Transfusion Transmission of HIV 1. Past & Current Risk Estimates of Transfusion-Transmitted HIV Infection 2. Layers of Safety in Protection of the Blood.
Final Project Presentation Guidelines Each group has 12 minutes MAX PowerPoint available for use –Save presentation to Group Web Page and bring CD- rom.
Why "We" should Care Presented to: International Blood Safety Forum Jed Gorlin MD, MBA March 20, 2015 ©2015 Innovative Blood Resources, Proprietary & Confidential.
CHALLENGES IN DONOR RECRUITMENT IN THIRD WORLD COUNTRIES, ( THE CASE OF KENYA)
Management of Risk and Blood Availability in Donor Populations with High Prevalence of Blood Borne Pathogens Ravi Reddy IBSF Meeting 20 March 2015.
Blood Transfusion. BenefitsRisks Risks & Benefits There is no doubt that Blood Transfusion is an integral part of everyday hospital life and like most.
HealthSanté CanadaCanada Influenza Prevention and Control in Canada Arlene King, MD, MHSc, FRCPC Director, Immunization and Respiratory Infections Division,
The Journey of Blood. Blood - the life source Slide 1: Blood is a scarce and vital resource which saves lives and improves the health of millions. Its.
Lookback study for transfusion- related HBV infection in Japan Tokyo Metropolitan Red Cross Blood Center Masahiro Satake.
Surveillance of HIV infection
Right Patient, Right Blood
TRANSFUSION SAFETY AN INTERNATIONAL FLAVOR. RISK DATA – U.S. Motor cycling 1:50 20 Cigarettes/d 1:200 Hit by car 1:20,000 BC pills 1:50,000 Earthquake.
Pan American Health Organization Health in the Americas: Regional Challenges and Strategic Directions Dr. Carissa Etienne Assistant Director SUMMIT IMPLEMENTATION.
And the order changeth …. Evolving protocols for TTI testing
Reentry for Donors Deferred Based on Anti-HBc Test Results November 3, 2005 BPAC Meeting FDA/CBER/OBRR/DETTD.
Harold S. Margolis, M.D. Division of Viral Hepatitis
IN THE NAME OF GOD Blood Safety S. AMINI KAFI ABAD CLINICAL AND ANATOMICAL PATHOLOGIST IRANIAN BLOOD TRANSFUSION ORGANIZATION(IBTO) RESEARCH CENTER June.
PAHO Pan American Health Organization Pan American Sanitary Bureau Regional Office for the Americas for the World Health Organization.
 Fact1: Caribbean Country  Fact2: on of the poorest country in the Americas  Fact3: it was the first independent nation in Latin America.
21th VHPB meeting on “Prevention of viral hepatitis in Italy: lessons learnt and the way forward” Catania, 7-8 november 2002 RESIDUAL RISK OF TRANSFUSION-
Maria Rios, Ph.D. CBER/FDA Blood Products Advisory Committee May 1st, WNV Epidemiology & FDA’s Recommendations on the Use of NAT to Reduce the.
Challenges in evaluating and changing donor criteria Dr. Mindy Goldman Transfusion Medicine Residents April 30, 2008.
1 Donor’s Written Statement of Understanding Beth H. Shaz, MD Chief Medical Officer New York Blood Center Clinical Associate Professor Emory University.
Why donate blood? Sankalp India Foundation. Every 2 minutes Someone in Bangalore needs blood.
Review Map Test. Latitude measures North and South. The equator is a line of latitude.
Rotary District 5790 Blood Donation & Blood Challenge
Presented by: Stephanie Johnson Emma Okul John Monroe Samantha Parks AMERICAN RED CROSS.
Return on investment: How do whole societies benefit from improved services and coverage for key populations? Bradley Mathers Kirby Institute UNSW Australia.
Department of Health and Human Services Office of the Assistant Secretary for Health (ASH) Advisory Committee on Blood Safety and Availability (ACBSA)
S The European Up-Front Risk Assessment Tool (EUFRAT) The European Up-Front Risk Assessment Tool (EUFRAT) (EUFRAT)
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Caribbean Cervical Cancer Prevention and Control Program By Corey Spellman COMM337.
Our tryst with Nucleic Acid Testing Dolly Daniel, Dept of Transfusion Medicine, CMC, Vellore.
K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.
XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.
MAIN ISSUES FOR 62 nd EXCOM MEETING Joint Meeting of the Latin American and Caribbean Networks of Ozone Officers Mexico City, Mexico, 6 -8 October 2010.
HIV/AIDS Prevalence & Mortality Report, 2012 Minnesota Department of Health HIV/AIDS Surveillance System Minnesota Department of Health HIV/AIDS Surveillance.
Organ Donation By Mike Gallacher. Lance Armstrong & Terry Box.
HHS Secretary’s Advisory Committee on Blood Safety and Availability Summary for FDA’s BPAC July 2010 Jerry A. Holmberg, Ph.D. Senior Advisor for Blood.
Identification and Deferral of Tissue Donors for Possible BSE/vCJ-D Exposure: Estimating the Impact Alan E. Williams, Ph.D. Director, Division of Blood.
Deferral of Blood and Plasma Donors for History of Transfusion in BSE Countries of Europe Alan E. Williams, Ph.D. Director, Division of Blood Applications.
NAT as part of routine tests ? I disagree ! Dr Anjali Arun Mysore.
1 Update on Study to Further Define the Incidence of T. cruzi Infection in the US Blood Donor Population Susan L. Stramer, PhD American Red Cross BPAC.
Transfusion Related Acute Lung Injury (TRALI)
45 th Session Advisory Committee on Health Research of the Pan American Health Organization (CAIS) Hamilton, ON, Canada 17 – 19 October 2012 Partnerships.
Industrial Hygiene Database Mark Klein, GAF ARMA Health, Safety, and Environment Committee.
Prevalence of HIV infection among blood donors at the National Blood Transfusion Centre in Bangui, Central African Republic Claudine Bekondi1a, Pulchérie.
Introduction Results Conclusions Methods
Higher Prevalence of HbsAg among Blood Donors at a tertiary care center in greater Gwalior: A 5years study ( TTI-12 : D-1182 ) Dr. Anita Arya, Dr. Sachin.
Another Great Leap Forward
Antiretroviral therapy coverage in sub-Saharan Africa,
Gaining Informed Transfusion Consent
Intraoperative Cell Salvage
Western & Central Europe
Ortega, J., Hooshmand, M., Padron, M., Cassiani, S. & Peragallo, N.
International IHR NFP Presentation
Global summary of the HIV and AIDS epidemic, 2005
VOLUNTARY BLOOD DONATION TERUMO PENPOL Limited
Global summary of the HIV and AIDS epidemic, 2005
Distribution of confirmed measles cases by sub national level
Complementary algorithm for serological testing of specimens with an initial IgM-positive or indeterminate result 5 Collect an adequate serum sample within.
REGULATORY ISSUES Federal Law No. 125-FZ of June 20, 2012 «On the donation of blood and its components». Order No. 183n. dated April 2, 2013 of the Ministry.
Presentation transcript:

BLOOD TRANSFUSION SAFETY: PROGRESS REPORT 142 nd Session of the Executive Committee June 2008, Washington DC Pan American Health Organization 142 nd Session of the Executive Committee June 2008, Washington DC Pan American Health Organization

Pan American Health Organization COVERAGE OF SCREENING FOR TTI LATIN AMERICA AND CARIBBEAN %

Pan American Health Organization PARTICIPATION IN PEEP FOR TTI VOLUNTARY BLOOD DONATION LATIN AMERICA %

Pan American Health Organization RISK OF INFECTED TRANSFUSIONS * * per 100,000 donations

Pan American Health Organization EFFICIENCY OF BLOOD COLLECTION LATIN AMERICAN COUNTRIES, 2005 N UNITS1,4042,3345,888p< DONATION RATE/10,000 (95% CI) ( ) ( ) ( ) P<0.005 VBD (MEAN) p<0.010 DONOR DEFERRAL (%) p<0.050 MEAN UNITS DISCARDED (%) p> 0.90

Pan American Health Organization EFFICIENCY OF BLOOD COLLECTION CARIBBEAN COUNTRIES 2005 COUNTRIES WITH DERERRAL RATE 20-53% (n=8) COUNTRIES WITH DEFERRAL RATE 0-10% (n=7) DONATION RATE (MEDIAN) COUNTRIES WITH 100% VBD 0/84/7 PREVALENCE TTI (MEDIAN) DISCARD RATE (MEAN)

Pan American Health Organization FINANCIAL RESOURCES LOST LATIN AMERICAN AND CARIBBEAN COUNTRIES 2005 LATIN AMERICACARIBBEAN # UNITS REACTIVE/POSITIVE FOR TTI 235,1343,562 # UNITS OF RBC OUTDATED & DISCARDED 603,9506,425 TOTAL UNITS LOST839,0849,987 TOTAL COST US $ 56/UNIT ,272

Pan American Health Organization THE WAY FORWARD HEALTH AUTHORITIES LEAD PLANNING AND MANAGEMENT OF NATIONAL BLOOD NETWORK SYSTEMS NEED FOR BLOOD COMPONENTS AT THE NATIONAL LEVEL IS ESTIMATED A SOCIAL NETWORK IS FORMED AND BLOOD DONORS ARE EDUCATED REPLACEMENT AND PAID DONATIONS ARE TERMINATED